Gingival hyperplasia is an abnormal overgrowth of gum tissue that can partially or completely cover the teeth, interfering with chewing, speech, and oral hygiene. It goes by several names in clinical settings, including gingival enlargement, gingival overgrowth, and gingival fibromatosis, but they all describe the same core problem: the gums grow beyond their normal size, often becoming firm, pink, and lobulated or, in inflammatory cases, red, soft, and prone to bleeding. The condition has a surprisingly wide range of triggers, from common prescription medications to rare inherited gene mutations, and the right treatment depends entirely on which cause is at work.
Why Gums Overgrow in the First Place
At the tissue level, gingival hyperplasia comes down to an imbalance between how fast connective-tissue components are built and how fast they are broken down. Gum tissue is rich in fibroblasts, the cells responsible for producing collagen and other structural proteins. In a healthy mouth, old collagen is steadily broken down by enzymes so that the tissue stays in equilibrium. When something disrupts that balance, collagen and related molecules called glycosaminoglycans pile up in the extracellular matrix, and the gum physically expands.1PubMed Central. On the Cellular and Molecular Mechanisms of Drug-Induced Gingival Overgrowth The fibroblasts and the outer layer of gum cells (keratinocytes) both show altered behavior, with reduced collagen-degrading enzyme activity and changes in surface receptors called integrins that help regulate tissue turnover.2PubMed Central. Drug-Induced Gingival Overgrowth-Molecular Aspects of Drug Actions
That imbalance can be triggered by drugs, by chronic inflammation from dental plaque, by hormonal shifts, by certain blood cancers, or by inherited mutations. Each trigger nudges the fibroblasts in a slightly different way, but the end result is the same visible swelling.
The Three Drug Classes That Cause It
Medications are by far the most commonly discussed cause. Three drug classes account for nearly all drug-induced cases: anticonvulsants, calcium channel blockers, and immunosuppressants. Within each class, one drug tends to be the main offender.
Anticonvulsants and Phenytoin
Phenytoin (once sold as Dilantin) was the first drug recognized to cause gum overgrowth, and it remains the most studied. It works against seizures by stabilizing electrical activity in the brain, but in the gums it appears to push fibroblasts toward making more collagen while simultaneously blocking the enzymes that break collagen down. Specifically, phenytoin inhibits collagen-degrading enzymes known as matrix metalloproteinases and promotes their inhibitor, TIMP-1, so collagen accumulates in the tissue.3The Open Dentistry Journal. An Update on the Mechanisms of Phenytoin Induced Gingival Overgrowth The overgrowth tends to start at the small triangles of gum between the teeth (the interdental papillae) and can eventually cover the crowns of the teeth entirely. Inflammation from plaque appears to amplify the process: studies show that the inflammatory environment in gum tissue helps orchestrate the interaction between phenytoin and fibroblasts.4PubMed Central. Phenytoin-induced gingival overgrowth: a review of the molecular, immune, and inflammatory features
Calcium Channel Blockers and Nifedipine
Calcium channel blockers are prescribed for high blood pressure and certain heart conditions. Nifedipine was the first one linked to gum overgrowth, and amlodipine is another common culprit. These drugs relax blood vessel walls by blocking calcium ion channels, but those same channels exist in gum fibroblasts, and blocking them disrupts normal tissue homeostasis.5PubMed Central. Management of amlodipine-induced gingival enlargement: Series of three cases Under the microscope, gum tissue affected by nifedipine shows increased numbers of fibroblasts packed with sulfated mucopolysaccharides and collagen-producing secretory granules, a pattern strikingly similar to what phenytoin causes.6PubMed. Nifedipine-induced gingival hyperplasia. A histochemical and ultrastructural study The clinical appearance can range from mild swelling of the interdental papillae to massive tissue enlargement that engulfs the teeth.
Immunosuppressants and Cyclosporine
Cyclosporine is used to prevent organ rejection after transplant surgery and to treat certain autoimmune conditions. It causes gum overgrowth through mechanisms that overlap with both phenytoin and calcium channel blockers, which creates a particularly unfortunate problem: transplant patients who take cyclosporine often also need a calcium channel blocker for post-transplant high blood pressure. In a study of 106 transplanted children, those who received cyclosporine plus nifedipine had significantly worse gingival overgrowth than children on either drug alone.7PubMed. Nifedipine aggravates cyclosporine A-induced gingival hyperplasia Animal studies confirmed the same additive effect, with the combination of cyclosporine and nifedipine producing the most severe tissue growth among all tested drug groups.8PubMed. Effects of combined oral treatments with cyclosporine A and nifedipine or diltiazem on drug-induced gingival overgrowth in rats
Plaque, Inflammation, and the Role of Oral Hygiene
Even without any medication, chronic plaque buildup can produce gum enlargement on its own. Bacterial biofilm on the teeth triggers an inflammatory response in the gum tissue, and prolonged inflammation leads to swelling, redness, and sometimes a thickened, puffy appearance that clinicians classify as inflammatory gingival enlargement. A key characteristic of this type is reversibility: remove the plaque and the inflammation resolves, and the tissue typically returns to normal.9PubMed. Dental plaque-induced gingival conditions
What makes plaque especially relevant, though, is how it interacts with the other causes. In drug-induced cases, poor oral hygiene is consistently identified as an aggravating factor. The inflammatory environment seems to prime the gum tissue, making fibroblasts more susceptible to whatever drug is circulating. This is why the severity of drug-induced overgrowth can vary dramatically between two patients on the same medication at the same dose: the one with worse plaque control often has worse overgrowth. Patients with gingival fibromatosis from inherited causes also face compounding plaque problems because the enlarged tissue creates deep pockets that are extremely difficult to clean, trapping more bacteria and driving more inflammation in a self-reinforcing cycle.10PubMed Central. Idiopathic gingival fibromatosis and primary analysis of dominant bacteria in subgingival biofilm: a case report
Hereditary Gingival Fibromatosis
A much rarer form of gum overgrowth is hereditary gingival fibromatosis (HGF), which runs in families and has nothing to do with medications or plaque. The most studied subtype, HGF type 1, has been traced to a mutation in the SOS1 gene. Researchers identified a single-nucleotide insertion in the gene that introduces a frameshift and a premature stop signal, which ultimately disrupts normal cell signaling and causes unchecked tissue growth in the gums.11PubMed Central. A mutation in the SOS1 gene causes hereditary gingival fibromatosis type 1 The mutation was found in every affected family member studied and was absent in all unaffected relatives and unrelated controls.12American Journal of Human Genetics. A Mutation in the SOS1 Gene Causes Hereditary Gingival Fibromatosis Type 1
HGF typically appears when the permanent teeth start coming in, around age six or seven. The overgrown tissue is firm, dense, and heavily collagenized rather than red and inflamed. In children, the main complications include drifting of teeth from their normal positions, prolonged retention of baby teeth, gaps between teeth, and difficulty maintaining oral hygiene.13PubMed. Gingival overgrowth in children: epidemiology, pathogenesis, and complications HGF is the most common syndromic gingival enlargement in children, though “common” is relative here since it remains a rare condition overall.
Hormonal Shifts and Gum Tissue
Hormones, especially estrogen and progesterone, can temporarily push gum tissue toward enlargement. During puberty, pregnancy, and parts of the menstrual cycle, rising levels of these hormones increase blood flow to the gums and amplify the inflammatory response to even small amounts of plaque.14PubMed Central. The influence of sex steroid hormones on gingiva of women Estrogen alters blood vessels in the gum tissue, while progesterone stimulates inflammatory mediators. The result can be puffy, bleeding gums that look disproportionate to the amount of plaque present.
Puberty gingivitis is the classic example in adolescents. It is primarily triggered by dental plaque, but the hormonal surge exaggerates the gum tissue’s response far beyond what would occur at other life stages.15PubMed Central. Puberty-Associated Gingival Enlargement Exacerbated by Polycystic Ovary Syndrome: A Case Report Pregnancy produces a similar but often more dramatic effect. With heightened estrogen and progesterone levels sustained over months, pregnancy gingivitis can involve marked swelling, tenderness, and bleeding that usually resolves after delivery as hormone levels return to baseline.16PubMed Central. Understanding the Link Between Hormonal Changes and Gingival Health in Women: A Review Certain oral bacteria can actually metabolize steroid hormones, which may further amplify the effect.
When Gum Overgrowth Signals Something More Serious
In rare cases, gingival hyperplasia is the first visible sign of a systemic disease, particularly blood cancers such as leukemia. Certain types of acute myeloid leukemia cause immature white blood cells to infiltrate the gum tissue, producing rapid and sometimes dramatic enlargement. In one documented case, gingival hyperplasia was the initial oral manifestation that led to a diagnosis of acute myeloid leukemia after investigation revealed blast cells of myelomonocytic origin in the gum tissue.17PubMed Central. Gingival hyperplasia: An initial oral manifestation of acute myeloid leukemia
Vitamin C deficiency (scurvy) is another systemic condition that can present as gum problems, including swelling and bleeding. While scurvy is uncommon today, it still appears in people on severely restricted diets. In at least one case, a young child on a limited diet presented with gingival inflammation as the primary symptom, and dental professionals were the first point of contact for what turned out to be vitamin C deficiency.18PubMed Central. Scurvy presenting primarily as gingival manifestation in a young child: a diagnostic dilemma The important takeaway is that unexplained gum swelling, especially when it does not respond to improved oral hygiene, warrants investigation beyond the mouth itself.
Telling One Cause from Another
Because gingival enlargement has so many possible causes, diagnosis is often a process of elimination rather than a single test. The clinical presentation varies: drug-induced overgrowth usually starts between the teeth and can be firm and fibrous; inflammatory enlargement tends to be red, soft, and bleeds easily; hereditary fibromatosis is dense and symmetrical; and leukemic infiltration often appears suddenly with a purplish discoloration. But these patterns overlap considerably, and the presentations can be challenging for clinicians to distinguish on appearance alone.19PubMed Central. Gingival enlargements: Differential diagnosis and review of literature
A thorough drug history is usually the first step. If a patient is on phenytoin, cyclosporine, or a calcium channel blocker, the diagnosis often becomes straightforward. When no drug is involved, a dentist or periodontist may order blood work to rule out leukemia or nutritional deficiencies, or request a biopsy to examine the tissue under a microscope. Family history matters too: if parents or siblings had similar gum problems starting in childhood, HGF moves to the top of the list.
Treatment Without Surgery
The first-line approach for drug-induced gingival hyperplasia is almost always non-surgical. This typically involves three steps: improving plaque control, professional scaling and root planing (a deep cleaning that removes plaque and calculus from below the gumline), and, when medically feasible, switching the offending drug to an alternative. Stopping or changing the drug combined with rigorous plaque control often leads to partial or complete regression of the overgrowth.20PubMed Central. Drug-induced gingival overgrowth: A critical insight into case reports from over two decades
A concept called full-mouth disinfection, where the entire mouth is treated in a short time frame to prevent bacteria from reinfecting freshly cleaned areas, has shown promise. In cases treated this way, all clinical measures improved significantly without any need for surgery.21PubMed Central. Treatment of drug-induced gingival overgrowth by full-mouth disinfection: A non-surgical approach In one case series, a patient who switched from a calcium channel blocker to a different type of blood pressure medication (losartan potassium with hydrochlorothiazide) saw a good result with initial periodontal treatment alone, no surgery required.22PubMed Central. Clinical presentation and management of drug-induced gingival overgrowth: A case series Non-surgical strategies also help limit recurrence and reduce plaque-driven inflammation, so they are generally recommended as the first step regardless of severity.23PubMed. The management of drug-induced gingival overgrowth
Drug substitution is not always an option, however. A transplant patient on cyclosporine cannot simply stop taking it. A person with epilepsy may have tried and failed other anticonvulsants before landing on phenytoin. In those cases, the treatment plan focuses on maximizing plaque control and reserving surgery for overgrowth that is severe enough to impair function.
Surgical Options and How They Compare
When non-surgical treatment is not enough, the standard procedure is gingivectomy, where the excess tissue is cut away. This can be done with a traditional scalpel, an electrosurgery device, or a laser. All three approaches effectively reduce the overgrowth, and all outperform non-surgical treatment alone for tissue reduction.24Nova Southeastern University. Comparing the Efficacy of Scalpel, Electrosurgical, and Laser Gingivectomies for the Management of Gingival Enlargement Following Orthodontic Therapy
The differences between them are modest. One trial comparing all three techniques for drug-induced overgrowth found that laser excision had significantly less recurrence at six months than conventional scalpel gingivectomy. Flap surgery, a more involved approach where the tissue is lifted and repositioned, offered no advantage over the simpler scalpel method.25PubMed. The efficacy of three different surgical techniques in the management of drug-induced gingival overgrowth Another study comparing diode laser and electrocautery found no significant difference in pain, healing time, or overall outcomes, concluding that the two are essentially interchangeable.26PubMed Central. Comparative evaluation of healing after gingivectomy with electrocautery and laser Most patients in surgical studies reported electrocautery as causing the most post-operative discomfort, with laser slightly less uncomfortable and scalpel least of the three.
Recurrence is the central frustration with surgery. If the underlying cause persists, whether that is an ongoing medication or a genetic condition, the tissue often grows back. Recurrence rates vary widely in the literature, and few studies have directly compared techniques with long-term follow-up. For hereditary gingival fibromatosis in particular, repeated surgeries over a lifetime are the norm rather than the exception.
Can Strict Oral Hygiene Prevent Drug-Induced Overgrowth?
This is one of the more frustrating findings in the research. While poor plaque control clearly worsens drug-induced gum overgrowth, excellent plaque control does not reliably prevent it. A two-year study that put patients on a rigorous plaque control program found that the development of phenytoin-induced overgrowth could not be prevented by the program.27PubMed. The effect of a plaque control program on the development of phenytoin-induced gingival overgrowth. A 2-year longitudinal study That does not mean oral hygiene is pointless. Good plaque control reduces the severity and extent of the overgrowth, decreases gum inflammation, and lowers the recurrence rate after treatment.28PubMed. The management of drug-induced gingival overgrowth Think of it as the difference between managing the condition effectively and curing it: hygiene manages, but cannot override the drug’s direct effect on fibroblast behavior.
How Gingival Hyperplasia Affects Daily Life
The physical consequences of gum overgrowth are obvious: difficulty chewing, problems with speech when tissue covers the biting surfaces, and an increased risk of cavities because overgrown gums make it nearly impossible to brush and floss properly. In children, severe enlargement can delay the eruption of permanent teeth.29PubMed. Gingival overgrowth in children: epidemiology, pathogenesis, and complications
The psychological burden is less discussed but can be substantial. Severe overgrowth changes the appearance of the smile and mouth, and patients report being avoided or stigmatized by friends and family because of the way their gums look.30PubMed Central. Idiopathic Gingival Enlargement Causing Social Stigma In adolescents, the impact is especially pronounced. Gingival edema and bleeding in the front of the mouth are associated with worse quality-of-life scores on validated questionnaires designed for that age group.31Brazilian Oral Research. Edema and gingival bleeding in anterior region have a negative influence on quality of life of adolescents A case report of a 15-year-old girl with severe phenytoin-induced overgrowth documented a quality-of-life score of 52 out of 56 at baseline (where higher means worse), reflecting near-total impairment across physical, psychological, and social domains. After drug substitution and professional periodontal treatment, her score dropped to 15, a 70 percent improvement, with particularly sharp decreases in psychological discomfort and social disability.32PubMed Central. Periodontal Management to Improve Oral Health-related Quality of Life in an Adolescent Girl with Phenytoin-induced Gingival Enlargement: A Case Report
The Combination Drug Problem in Transplant Patients
Organ transplant recipients face a uniquely difficult version of this condition. Cyclosporine remains a cornerstone of anti-rejection therapy for many patients, and post-transplant hypertension is common enough that a calcium channel blocker is often added. As the pediatric transplant data showed, combining cyclosporine with nifedipine produces worse overgrowth than either drug alone.33PubMed. Nifedipine aggravates cyclosporine A-induced gingival hyperplasia Switching to a blood pressure medication from a different class can help. Losartan, an angiotensin receptor blocker, does not affect gum tissue in the same way, and case evidence supports the strategy of substituting it for calcium channel blockers when possible.34PubMed Central. Clinical presentation and management of drug-induced gingival overgrowth: A case series In transplant medicine, newer immunosuppressants like tacrolimus have a lower reported incidence of gum overgrowth than cyclosporine, and some transplant programs have shifted toward tacrolimus partly for this reason, though the decision involves many other factors beyond gum health.
For patients who cannot change medications, a structured maintenance program with professional cleanings every three to four months, along with meticulous home care, is the realistic long-term strategy. Surgery may be needed periodically when the tissue becomes severe enough to interfere with function, but without addressing the drug component, recurrence is expected rather than surprising.